Skip to content
10-K

Annual Report

Adaptive Biotechnologies Corp ADPT

0001193125-26-076902

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 153.98M sh
Shares Diluted FY 2025 · Dec 31, 2025 151.72M sh
Shares Diluted FY 2025 · Dec 31, 2024 147.1M sh
Shares Diluted FY 2025 · Dec 31, 2023 144.38M sh
Capex FY 2025 · Dec 31, 2025 $2.96M
Capex FY 2025 · Dec 31, 2024 $3.66M
Capex FY 2025 · Dec 31, 2023 $10.7M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$45.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$95.21M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$156.32M
Long Term Debt FY 2025 · Dec 31, 2025 $126.57M
Long Term Debt FY 2025 · Dec 31, 2024 $132.41M
Short Term Debt FY 2025 · Dec 31, 2025 $4.64M
Short Term Debt FY 2025 · Dec 31, 2024 $865K
Cash And Equivalents FY 2025 · Dec 31, 2025 $70.5M
Cash And Equivalents FY 2025 · Dec 31, 2024 $47.92M
Stockholders Equity FY 2025 · Dec 31, 2025 $218.79M
Stockholders Equity FY 2025 · Dec 31, 2024 $202.71M
Current Liabilities FY 2025 · Dec 31, 2025 $89.92M
Current Liabilities FY 2025 · Dec 31, 2024 $98.05M
Total Liabilities FY 2025 · Dec 31, 2025 $287.74M
Total Liabilities FY 2025 · Dec 31, 2024 $336.89M
Current Assets FY 2025 · Dec 31, 2025 $300.19M
Current Assets FY 2025 · Dec 31, 2024 $283.75M
Total Assets FY 2025 · Dec 31, 2025 $512.74M
Total Assets FY 2025 · Dec 31, 2024 $539.38M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.39
Eps Diluted FY 2025 · Dec 31, 2024 −$1.08
Eps Diluted FY 2025 · Dec 31, 2023 −$1.56
Eps Basic FY 2025 · Dec 31, 2025 −$0.39
Eps Basic FY 2025 · Dec 31, 2024 −$1.08
Eps Basic FY 2025 · Dec 31, 2023 −$1.56
Sga Expense FY 2025 · Dec 31, 2025 $72.7M
Sga Expense FY 2025 · Dec 31, 2024 $72.81M
Sga Expense FY 2025 · Dec 31, 2023 $83.93M
Rd Expense FY 2025 · Dec 31, 2025 $93.77M
Rd Expense FY 2025 · Dec 31, 2024 $102.95M
Rd Expense FY 2025 · Dec 31, 2023 $122.12M
Net Income FY 2025 · Dec 31, 2025 −$59.5M
Net Income FY 2025 · Dec 31, 2024 −$159.49M
Net Income FY 2025 · Dec 31, 2023 −$225.25M
Operating Income FY 2025 · Dec 31, 2025 −$57.12M
Operating Income FY 2025 · Dec 31, 2024 −$162.55M
Operating Income FY 2025 · Dec 31, 2023 −$227.04M
Cost Of Revenue FY 2025 · Dec 31, 2025 $71.36M
Cost Of Revenue FY 2025 · Dec 31, 2024 $72.08M
Cost Of Revenue FY 2025 · Dec 31, 2023 $75.55M
Revenue FY 2025 · Dec 31, 2025 $276.98M
Revenue FY 2025 · Dec 31, 2024 $178.96M
Revenue FY 2025 · Dec 31, 2023 $170.28M